[1] Pape S, Schramm C, Gevers TJ. Clinical management of autoimmune hepatitis. United European Gastroenterol J, 2019, 7:1156-1163. [2] Sebode M, Hartl J, Vergani D,et al. Autoimmune hepatitis: From current knowledge and clinical practice to future research agenda. Liver Int, 2018, 38:15-22. [3] Minaga K, Watanabe T, Chung H, et al. Autoimmune hepatitis and IgG4-related disease. World J Gastroenterol, 2019, 25:2308-2314. [4] Pathak S, Kamat D. Autoimmune hepatitis in children. Pediatr Ann, 2018, 47:81-86. [5] Takahashi A, Ohira H. Autoimmune hepatitis, fatty liver, and Fukushima. Fukushima J Med Sci, 2019, 65:25-29. [6] Kerkar N, Chan A. Autoimmune hepatitis, sclerosing cholangitis, and autoimmune sclerosing cholangitis or overlap syndrome. Clin Liver Dis, 2018, 22:689-702. [7] Mack C L, Adams D, Assis D N, et al. Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the study of liver diseases. Hepatology, 2019, 72:671-722. [8] Gonzalez RS, Washington K. Primary biliary cholangitis and autoimmune hepatitis. Surg Pathol Clin, 2018, 11:329-349. [9] Castro C, Caballero J, Garavito J, et al. Autoimmune hepatitis and pregnancy: a case series. Rev Gastroenterol Peru, 2019, 39:292-298. [10] To U, Silveira M. Overlap syndrome of autoimmune hepatitis and primary biliary cholangitis. Clin Liver Dis, 2018, 22:603-611. [11] Rahim MN, Liberal R, Miquel R, et al. Acute severe autoimmune hepatitis: Corticosteroids or liver transplantation. Liver Transpl, 2019, 25:946-959. [12] Fu Y, Lin Q, Zhang Z, et al. Therapeutic strategies for the costimulatory molecule OX40 in T-cell-mediated immunity. Acta Pharm Sin B, 2020, 10:414-433. [13] He Y, Zhang X, Jia K, et al. OX40 and OX40L protein expression of tumor infiltrating lymphocytes in non-small cell lung cancer and its role in clinical outcome and relationships with other immune biomarkers. Transl Lung Cancer Res, 2019, 8:352-366. [14] Lei W, Zeng D, Liu G, et al. Crucial role of OX40/OX40L signaling in a murine model of asthma. Mol Med Rep, 2018, 17:4213-4220. [15] Kashima J, Okuma Y, Hosomi Y, et al. High serum OX40 and OX40 ligand (OX40L) levels correlate with reduced survival in patients with advanced lung adenocarcinoma. Oncology, 2020, 98:303-310. |